CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial
← catalyst calendarSponsored by BioCardia, Inc. (industry) · BCDA — their whole pipeline →.
Phase
Not applicable
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · Quadruple · Treatment
Enrollment
343estimated
Sites
2
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2021-06-30 | actual | When the study began enrolling |
| Primary completion | 2025-02-19 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Dec 2027 | estimated | The whole study's end, after follow-up |
| First posted | 2018-03-07 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-01-06 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Refractory Angina
- Chronic Myocardial Ischemia
Interventions
- Device: CardiAMP Cell Therapy System
- Other: Sham Treatment
Primary outcome
what the primary-completion date above is the date OFChange from Baseline in Total Exercise Time on the treadmill using the Modified Bruce Protocol
measured Baseline and 6 months visit
Permalink · BCDA's whole pipeline · Catalyst calendar · Every registered study · What changed